Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)

NCT05686408 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression
Depressive Disorder
Depressive Symptoms
Depressive Disorder, Major
Depressive Episode
Depression Severe

Interventions

DRUG: TNX-601 ER
DRUG: Placebo

Sponsor

Tonix Pharmaceuticals, Inc.

Collaborators

[object Object]